Capricor Therapeutics
CAPR
#7988
Rank
ยฃ0.21 B
Marketcap
ยฃ4.76
Share price
-4.36%
Change (1 day)
-59.72%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ62.82 Million

According to Capricor Therapeutics 's latest financial reports the company has ยฃ62.82 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ0.11 B553.39%
2023-12-31$ยฃ17.74 M82.1%
2022-12-31$ยฃ9.74 M-58.08%
2021-12-31$ยฃ23.23 M12.32%
2020-12-31$ยฃ20.68 M296.66%
2019-12-31$ยฃ5.21 M43.44%
2018-12-31$ยฃ3.63 M-56.23%
2017-12-31$ยฃ8.3 M-356.05%
2016-12-31$-ยฃ3.25 Million365.97%
2015-12-31$-ยฃ0.7 Million-82.65%
2014-12-31$-ยฃ4.02 Million1137.73%
2013-12-31$-ยฃ0.33 Million-110.71%
2012-12-31$ยฃ3.02 M466.58%
2011-12-31$ยฃ0.53 M-68.23%
2010-12-31$ยฃ1.68 M-8.72%
2009-12-31$ยฃ1.84 M-47.08%
2008-12-31$ยฃ3.48 M-54.49%
2007-12-31$ยฃ7.65 M-11219.59%
2006-12-31$-ยฃ0.07 Million52.86%
2005-12-31$-ยฃ0.05 Million47.06%
2004-12-31$-ยฃ0.04 Million34.58%
2003-12-31$-ยฃ0.03 Million48.68%
2002-12-31$-ยฃ0.02 Million148.05%
2001-12-31$-ยฃ0.01 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Cytokinetics
CYTK
-ยฃ0.4 Billion-721.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ4.79 Million-107.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ59.38 B 94,426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.24 B 3,481.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.44 B 613.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ2.67 M-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA